Two experimental compounds derived from a phase II metabolite have demonstrated improved anti-inflammatory activity in ...
A gene responsible for producing a critical enzyme in inflammatory signalling has been identified after more than 30 years, ...
A hybrid microrobotic platform combining living bacteria, nanoparticles and targeted chemotherapy has achieved 82.4 percent ...
PacBio and AI drug discovery company TychoBio are generating full-length RNA datasets from more than 10,000 samples to train ...
Researchers at Nagoya University have identified BCAT1, an enzyme involved in proline supply for collagen synthesis, as a ...
TechBio firm WhiteLab Genomics has closed a $26 million Series B round to expand in vivo validation of its AI-designed ...
Cambridge biotech bit.bio has released ioAstrocytes 2.0, a genetically matched human astrocyte model designed to support ...
Poor recovery, inconsistent growth and changes in morphology can affect organoid research. How much experimental variability ...
A new preclinical study reveals that KRAS-mutant gastric adenocarcinoma fosters a TGF-beta-dependent immunosuppressive tumour ...
Three leading scientists in protein science, structural biology and AI will headline the Protein Sciences in Drug Discovery ...
The right signals can make or break an organoid model. From growth and differentiation to downstream drug testing, cytokines and growth factors are critical to creating cultures researchers can rely ...
Penn State researchers have shown that inhibiting the protein VPS34 increases GD2 display on neuroblastoma cell surfaces, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results